Tryptophan Metabolites And Their Predicted Microbial Sources In Fecal Samples Of Healthy Individuals

Cynthia L. Chappell,Kristi L. Hoffman,Philip L. Lorenzi,Lin Tan,Joseph F. Petrosino,Richard A. Gibbs,Donna M. Muzny,Harsha Doddapaneni,Matthew C. Ross,Vipin K. Menon,Anil Surathu,Sara J. Javornik Cregeen,Anaid G. Reyes,Pablo C. Okhuysen

DOI: https://doi.org/10.1101/2023.12.20.572622

2024-02-01

Abstract:Gut microbiota produce tryptophan metabolites (TMs) important to homeostasis. However, measuring TM levels in stool and determining their microbial sources can be difficult. Here, we measured TMs from the indole pathway in fecal samples from 21 healthy adults with the goal to: 1) determine fecal TM concentrations in healthy individuals; 2) link TM levels to bacterial abundance using 16S and whole genome shotgun (WGS) sequencing data; and 3) predict likely bacterial sources of TM production. Within our samples, we identified 151 genera (16S) and 592 bacterial species (WGS). Eight TMs were found in ≥17 fecal samples, including four in all persons. To our knowledge, we are the first to report fecal levels for indole-3-lactate, indole-3-propionate, and 3-indoleacrylate levels in healthy persons. Overall, indole, indole-3-acetate (IAA), and skatole accounted for 86% of the eight TMs measured. Significant correlations were found between seven TMs and 29 bacterial species. Predicted multiple TM sources support the notion of a complex network of TM production and regulation. Further, the data suggest key roles for and IAA, a metabolite reported to maintain intestinal homeostasis through enhanced barrier integrity and anti-inflammatory/antioxidant activities. These findings extend our understanding of TMs and their relationship to the microbial species that act as effectors and/or regulators in the healthy intestine and may lead to novel strategies designed to manipulate tryptophan metabolism to prevent disease and/or restore health to the dysbiotic gut.

Microbiology

What problem does this paper attempt to address?

The main problem that this paper attempts to solve is to understand the concentrations of tryptophan metabolites (TMs) in the healthy human gut and their potential microbial sources. Specifically, the research objectives include:

1. **Determine the concentrations of tryptophan metabolites in the feces of healthy individuals**: By measuring tryptophan metabolites in fecal samples from 21 healthy adults, understand the baseline levels of these metabolites in the healthy population.
2. **Correlate tryptophan metabolite levels with bacterial abundances**: Utilize 16S and whole - genome sequencing (WGS) data to explore the relationships between tryptophan metabolite levels and the abundances of specific bacterial species.
3. **Predict the possible microbial sources of tryptophan metabolites**: Use the TrpNet tool to predict the bacterial species that may produce tryptophan metabolites and verify the consistency between these predictions and the actual measurement results.

### Main findings
- **Detection and measurement of tryptophan metabolites**: Eight tryptophan metabolites were detected in the study, and four of them were detected in all subjects. The main metabolites include indole (IND), indole - 3 - acetic acid (IAA), and skatole (SK), and these three metabolites account for 86% of the total amount of all detected metabolites.
- **Identification of bacterial species**: Through 16S and WGS sequencing, a total of 151 genera and 592 species were identified. Among them, 77 genera were predicted by TrpNet as possible tryptophan metabolite producers.
- **Correlation analysis**: Significant correlations were found between seven tryptophan metabolites and 29 bacterial species. For example, Collinsella aerofaciens is closely related to the production of IAA, and IAA is considered to maintain gut homeostasis by enhancing gut barrier integrity and anti - inflammatory and antioxidant effects.
- **Validation of the prediction model**: The effectiveness of the prediction model was further verified by calculating the prediction score (PS), which is the product of metabolite production probability (MPP) and bacterial relative abundance (%RA).

### Research significance
This study fills the gap in the research on tryptophan metabolites and their microbial sources in the healthy population and provides important data for understanding the role of gut microbiota and their metabolites in maintaining gut homeostasis. These findings are helpful for developing new strategies to prevent diseases or restore dysregulated gut health by regulating tryptophan metabolism.